Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
J Pharmacol Exp Ther ; 386(2): 212-223, 2023 08.
Article En | MEDLINE | ID: mdl-37188531

Recent advances in the RNA delivery system have facilitated the development of a separate field of RNA therapeutics, with modalities including mRNA, microRNA (miRNA), antisense oligonucleotide (ASO), small interfering RNA, and circular (circRNA) that have been incorporated into oncology research. The main advantages of the RNA-based modalities are high flexibility in designing RNA and rapid production for clinical screening. It is challenging to eliminate tumors by tackling a single target in cancer. In the era of precision medicine, RNA-based therapeutic approaches potentially constitute suitable platforms for targeting heterogeneous tumors that possess multiple sub-clonal cancer cell populations. In this review, we discussed how synthetic coding and non-coding RNAs, such as mRNA, miRNA, ASO, and circRNA, can be applied in the development of therapeutics. SIGNIFICANCE STATEMENT: With development of vaccines against coronavirus, RNA-based therapeutics have received attention. Here, the authors discuss different types of RNA-based therapeutics potentially effective against tumor that are highly heterogeneous giving rise to resistance and relapses to the conventional therapeutics. Moreover, this study summarized recent findings suggesting combination approaches of RNA therapeutics and cancer immunotherapy.


MicroRNAs , Neoplasms , Humans , RNA/genetics , RNA, Circular/genetics , RNA, Circular/therapeutic use , RNA, Small Interfering/therapeutic use , Neoplasms/therapy , Neoplasms/drug therapy , Oligonucleotides, Antisense/genetics , Oligonucleotides, Antisense/therapeutic use , RNA, Messenger
2.
Sci Rep ; 12(1): 16765, 2022 10 06.
Article En | MEDLINE | ID: mdl-36202918

Congenital hyperinsulinism (CHI) is a rare genetic condition characterized by uncontrolled insulin secretion, resulting in hypoglycemia. Although glucagon has lately been regarded as a therapeutic option for CHI, its use is severely hampered by its poor solubility and stability at physiological pH, as well as its short duration of action. To address these constraints, we developed HM15136, a novel long-acting glucagon analog composed of a glucagon analog conjugated to the Fc fragment of human immunoglobulin G4 via a polyethylene glycol linker. In this study, we established that HM15136 was more soluble than natural glucagon (≥ 150 mg/mL vs 0.03 mg/mL). Next, we confirmed that HM15136 activated glucagon receptor in vitro and induced glycogenolysis and gluconeogenesis in rat primary hepatocytes. Pharmacokinetics (PK)/Pharmacodynamics (PD) analysis of HM15136 shows that HM15136 has a markedly longer half-life (36 h vs. < 5 min) and increased bioavailability (90%) compared to native glucagon in mice. Further, HM15136 could effectively reverse acute hypoglycemia induced by insulin challenge, and multiple doses of HM15136 could sustain increased blood glucose levels in CHI rats. In conclusion, our findings indicate that HM15136 promotes sustained elevation of blood glucose, demonstrating the potential for development as a once-weekly therapy for CHI.


Congenital Hyperinsulinism , Hyperinsulinism , Animals , Humans , Mice , Rats , Blood Glucose/analysis , Congenital Hyperinsulinism/drug therapy , Glucagon , Half-Life , Hyperinsulinism/drug therapy , Immunoglobulin Fc Fragments , Insulin/pharmacology , Polyethylene Glycols/pharmacology , Receptors, Glucagon , Rodentia
3.
J Acoust Soc Am ; 140(1): 145, 2016 07.
Article En | MEDLINE | ID: mdl-27475140

For developing the quiet axial fans, the spatial distribution of acoustic source parameters over the source plane provides essential information. In this study, the previously suggested source identification technique by authors is newly applied to an axial fan. To obtain the acoustic source parameters in a duct, one should overcome many technical difficulties related with: the turbulent flow, high order modes, rotating sources, inverse estimation. Measurements are conducted with several arrays of flush mounted microphones deployed on the periphery of the duct wall. A reference trigger signal obtained from the rotating blade is used to suppress the effect of turbulent flow in the measured pressure spectra with a reduction of about 25 dB in the present work. The maximum error between measurement and estimation is generally <-20 dB in the measurement plane in the very vicinity to the source. The visualized source images clearly indicate the locations and the strengths of main contributors to the radiated sound, e.g., for the inlet of the axial fan, the tip clearance between fan blades and shroud wall.

...